For patients with multiple myeloma, the use of novel agents in first-line triplet and quadruplet induction regimens -- with ...

The finding that basophil counts may have prognostic significance aligns with a growing body of research into basophils in ...

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...

A Yale team of researchers led by noted Indian American oncologist Dr. Kiran Turaga has developed new national guidelines for ...

Jacobio Pharma (1167.HK) announced that it has submitted the Phase I/II Investigational New Drug (IND) application for its BET inhibitor JAB-8263 for the treatment of autoimmune diseases to the Center ...

Participants in the exercise program had a 37 percent lower risk of dying and a 28 percent lower risk of recurrent or new ...

Under the bill, The Congressional Budget Office said nearly 12 million more Americans would become uninsured by 2034.

Stage 3 lymphoma is a lymphatic cancer that has spread to lymph nodes above and below the diaphragm. Learn its symptoms, ...

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the rest.

This approval comes almost a year after the drug received a complete response letter due to third-party manufacturing issues.